CRE 360 Signal™

Life sciences real estate is showing two opposing signals: elevated vacancy and slowing leasing on one side, and major capital commitments and fund formation on the other. This episode explains why both are true and what the divergence means for 2026.
We break down the sector’s repricing, the impact of new institutional capital, Big Pharma investment, and the widening gap between core and secondary markets.
A concise, data-driven look at a sector in reset — not decline.
CRE360 Signal™.

What is CRE 360 Signal™?

A daily, three-minute market pulse for commercial real estate professionals who make real decisions.

Powered by CRE 360 Signal™, each episode distills the most relevant developments in credit, assets, and execution into clear, asset-level implications—what changed, why it matters, and where risk or opportunity is forming.

No long interviews.
No macro noise.
Just concise signal for investors, operators, lenders, and dealmakers who don’t have time to read—but still need to think clearly.